Parathyroidectomy is a surgical procedure used to treat hypercalcemia caused by primary hyperparathyroidism. This operation primarily targets lesions such as parathyroid adenomas, hyperplasia, or carcinomas, by removing part or all of the abnormal parathyroid tissue to reduce excessive secretion of parathyroid hormone (PTH) and restore blood calcium levels to normal ranges. The goal of the surgery is to resolve bone lesions, renal damage, and neurological and muscular symptoms caused by hypercalcemia, while reducing the risk of long-term complications.
This treatment is often indicated for patients with poor response to medication or significant organ damage. The surgical approach depends on the location and severity of the lesion. Postoperative monitoring of blood calcium and PTH levels is essential to ensure treatment efficacy. The procedure has a clear anatomical basis but must be performed by experienced surgeons to minimize complications.
Parathyroidectomy mainly includes total removal (removing all four glands), subtotal removal (preserving some normal glands), and partial removal (only removing the diseased gland). The choice depends on the extent of the lesion; for example, solitary adenomas are typically treated with partial removal. The mechanism involves removing the hyperfunctioning parathyroid tissue to decrease blood calcium levels and restore metabolic balance.
The surgery usually combines imaging-guided techniques (such as ultrasound or nuclear medicine imaging) to locate the abnormal glands, and may use nerve monitoring systems to protect the recurrent laryngeal nerve. After removal, residual glands or transplanted tissue can maintain basic PTH secretion to prevent permanent hypoparathyroidism. The procedure is performed under general anesthesia, with incisions often placed in the neck skin folds to minimize scarring.
The primary indication is for primary hyperparathyroidism, especially symptomatic hypercalcemia (blood calcium >10.5 mg/dL) or asymptomatic patients with persistent abnormal calcium levels. Other indications include recurrence after surgery, suspicion of malignancy, or cases unresponsive to medications such as bisphosphonates. Patients with chronic renal failure and secondary hyperparathyroidism may also benefit from surgery to improve calcium-phosphate metabolism disorders.
In special cases, such as familial hyperparathyroidism or diseases related to genetic mutations, surgery can be a definitive cure. However, other causes of secondary hypercalcemia (such as vitamin D intoxication) should be excluded, and the lesion must be confirmed to be located in the parathyroid glands.
This is an invasive surgical procedure performed under general anesthesia in the operating room. The process includes a neck incision, localization of the parathyroid glands, removal of the diseased tissue, and intraoperative frozen section pathology to confirm the lesion's extent. The operation lasts approximately 1-3 hours, with a hospital stay typically of 1-3 days, and full recovery taking 2-4 weeks.
There is no concept of "dosage," but the extent of resection is adjusted based on the severity of the lesion. For example, a solitary adenoma may only require removal of a single gland, while multiple lesions might necessitate total removal followed by transplantation of some tissue into the forearm muscles to preserve basic PTH secretion. Postoperative calcium and vitamin D supplementation should be adjusted according to blood calcium levels.
Compared to medication, surgery provides a permanent solution, especially beneficial for patients with recurrent kidney stones or severe bone density loss. Modern techniques (such as intraoperative nerve monitoring) also reduce the risk of laryngeal nerve damage, increasing patient acceptance.
Main risks include:
Other potential risks include wound healing issues or inadvertent removal of normal glands causing compensatory hypofunction. Severe complications such as permanent hypocalcemia may require lifelong calcium supplementation, necessitating strict monitoring. Preoperative assessment and intraoperative PTH monitoring can reduce these risks.
Contraindications include uncontrolled bleeding disorders, severe cardiopulmonary disease incompatible with anesthesia, or patient refusal. Preoperative ultrasound, sestamibi scan, or biochemical tests should be completed to confirm lesion localization.
Postoperative care includes calcium intake management, avoiding high-calcium foods to prevent hypocalcemia symptoms. Patients should avoid strenuous activity for at least 2 weeks and regularly monitor blood calcium and PTH levels. Immediate medical attention is required if swallowing difficulties or persistent hoarseness occur.
Surgery may interact with medications such as bisphosphonates; medications affecting bone metabolism should be discontinued before surgery. If patients are undergoing adrenal or thyroid surgery, combined procedures can reduce the risk of repeated anesthesia. Radiation therapy (such as radioactive iodine for thyroid cancer) may affect neck tissues, so informing the surgeon can help adjust the surgical plan.
Compared to medication, surgery eliminates long-term drug dependence but requires attention to postoperative calcium supplement interactions with other drugs (e.g., steroids). Multidisciplinary collaboration is key to successful treatment, with endocrinologists and surgeons jointly planning postoperative management.
Large studies show that for solitary parathyroid adenomas, the success rate of surgery reaches 95%, with 90% of patients achieving normalization of blood calcium postoperatively. Long-term follow-up indicates that patients with autotransplantation have a low risk (<10%) of long-term hypocalcemia.
For secondary hyperparathyroidism (such as in chronic kidney failure), surgery effectively reduces blood calcium and improves renal function indicators. Randomized controlled trials confirm that surgery significantly reduces fracture and kidney stone incidence compared to medication, making it the preferred treatment for hypercalcemic crises.
Non-surgical options include:
While medications can temporarily control symptoms, they do not cure the condition and may cause renal toxicity. Radiation therapy may increase the risk of secondary malignancies. Therefore, surgery remains the primary treatment for most cases of hyperparathyroidism.
What preparations are necessary before surgery to ensure a smooth operation?
Preoperative preparations include comprehensive examinations such as blood tests, parathyroid scans, or ultrasound to confirm lesion location. Patients should fast for 12 hours before surgery and suspend certain medications (e.g., anticoagulants) as directed by the physician. Medical staff will explain potential postoperative symptoms and management strategies to ensure patients and their families are well-informed about the procedure.
How to recognize and manage symptoms of hypocalcemia after surgery?
Some patients may experience symptoms such as numbness, muscle cramps, or palpitations due to transient suppression of parathyroid function. Physicians will prescribe calcium and vitamin D supplements based on blood calcium levels, with regular blood tests during follow-up. Sudden worsening of symptoms warrants immediate medical attention for medication adjustment.
When can patients resume normal activities after surgery? What precautions should be taken?
Light activities such as short walks can usually start 1-2 days post-surgery, but lifting heavy objects or vigorous exercise should be avoided for at least 2-4 weeks. Full-time work recovery varies but generally takes 2-6 weeks. Wound care includes avoiding water contact for the first 2 weeks and monitoring for bleeding or infection.
What is the long-term success rate of parathyroidectomy?
For primary hyperparathyroidism, minimally invasive surgery has a success rate of about 90%-95%, with recurrence rates of 1%-5%. For tumors or multiple gland disease, more extensive resection may be necessary. Long-term follow-up shows that over 85% of patients maintain normal blood calcium and PTH levels postoperatively, though some may require long-term calcium supplementation.
What dietary adjustments are recommended to promote recovery?
Initial postoperative diet should be low in calcium to reduce renal burden, but long-term intake should be adjusted based on blood calcium levels. Foods rich in magnesium and vitamin D (such as dark leafy greens and fish) are recommended, while excessive caffeine or high-phosphorus foods should be avoided to maintain calcium-phosphate balance. Personalized dietary plans should be developed by the healthcare provider based on individual conditions.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
